Intellia Therapeutics

Youtube Subscribe

Open: 24.81 Close: 24.59 Change: -0.22

Our AI found 6 flaws in Intellia Therapeutics Company Inc Stock.

How much time have you spent trying to decide whether investing in Intellia Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: …

Concept Map

Semantic Network

Stock Summary

Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Director Munani Bhanj now holds 12.

Today's Summary

Intellia Therapeutics stock is falling after falling after the company announced a public offering on Thursday. NTLA stock jumped on the implications of the companys public offering, though some concerns linger.

Today's News

Intellia Therapeutics announced the publication of encouraging interim Phase 1 data for NTLA-2002, a treatment for Hereditary Angioedema, in the New England Journal of Medicine through a press release on January 31, 2024. Intellias stock is up 6% on data from an early-stage trial. Intellia Therapeutics stock is falling after falling after the company announced a public offering on Thursday. NTLA stock jumped on the implications of the companys public offering, though some concerns linger. Intellia Therapeutics Inc 10,857 $24.39 $0.90 (3.56%) Today Market Cap $2.26B Volume (M) 457,583.00 52-Wk High $47.48 52- Wk High $22.67 52-wk Low $23.81 Aroon Indicator entered a Downtrend on January 31, 2024 and more modest Tives nailsascusmusFI pouring taxes Overt Examination Intellia Therapeutics price would move from $40.10 to $82.43, which is up 106% in five years. The short-term forecast: Tuesday, Feb 6 - $25.31 Wednesday, Feb 7 - $26.32 Thursday, Feb 8 - $24.68 Friday, Feb 9 - $27.56 Monday, Feb 12 - $29.94. The forecasted price of Medium Inletty studied engοvisory envis Vas graphic Intellia Therapeutics price started in 2024 at $30.49. Today, Intellya Therapeutic traded at $28.63, so the price decreased by -6% from the beginning of the year. The forecasted price at the end of 2024 is $33.35 - and the year to year change +9%. In the middle of 2024, we expect to see $32.94 per 1 Intellults mural armor frepson obstructionippingiovascular268 Intellia Therapeutics price would move from $37.15 to $85.07, which is up 129% up 129%. The forecasted price at the end of 2023 is $34.90 - and the year to year change 0%. In the first half of 2024, the price will climb to $40.54; in the second half, price would add $256 and close the year at $41.14.1: @ Corp anxious --well Intellia Therapeutics Inc last close Feb 05 • 10:57AM ET 24.24 Dollar change -1.05 Percentage change -4.15% Intellia Therapeutics raised $85M in its IPO in 2014. Investors include Atlas Venture, Novartis Venture Funds, Fidelity Investments. Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones 12 days ago - GlobeNewsWire Intellya Therapeutic Highlights its three-year strategic Priorities, and anticipated 2024 key milestones.

Stock Profile

" Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Cyndeo Wealth Partners LLC acquired a new position in Intellya Therapeutic, Inc. in Stock. Intellia Therapeutics is anticipated to post earnings of ($4.05) per share for the year. This forecast comes amidst a consensus estimate of $5.33 per share. Director Muna Bhanji now holds 12,526 shares in the company valued at $492,271. Wall Street analysts think its a good time to buy Intellia Therapeutics stock. Out of 16 sell side analysts who give forecasts on NTLA, the consensus analyst rating is a Strong Buy. NTLA does not generate passive income. Cambridge, MA, is hiring associate director, clinical data management in cambridge, massachusetts, united states. Sandia Investment Management LP acquired a new position in shares of Intellia Therapeutics in the fourth quarter valued at approximately $35,000. CWM LLC boosted its holdings in shares by 2,072.7% in the first quarter. Raymond James & Associates owns 0.06% of Intellia Therapeutics worth $1,972,000 at the end of the most recent quarter. Director Muna Bhanji sold 1,867 shares of the businesss stock in a transaction on Thursday, July 6th."

Keywords

Are looking for the most relevant information about Intellia Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Intellia Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, price, year, Feb, change, stock, and the most common words in the summary are: therapeutic, intellia, stock, price, year, company, inc, . One of the sentences in the summary was: NTLA stock jumped on the implications of the companys public offering, though some concerns linger.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #intellia #stock #price #year #company #inc.

Read more →

Youtube Subscribe

---